JDS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Interpretive Summary
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by von Buenau, R.
Right arrow Articles by Krueger, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by von Buenau, R.
Right arrow Articles by Krueger, M.
J. Dairy Sci. 88:317-323
© American Dairy Science Association, 2005.

Escherichia coli Strain Nissle 1917: Significant Reduction of Neonatal Calf Diarrhea

R. von Buenau1, L. Jaekel2, E. Schubotz3, S. Schwarz4, T. Stroff5 and M. Krueger6

1 Dr. Ponsold GmbH, Department of Animal Health, Breitscheidstrasse 28a, 39387 Oschersleben, Germany
2 Jonastal 8, 99310 Arnstadt, Germany
3 F 41, 04523 Elstertrebnitz, Germany
4 Am Silberberg 10, 08396 Oberwiera, Germany
5 Holzwickeder Str. 49a, 59427 Unna, Germany
6 Institute for Bacteriology and Mycology, Veterinary Medicine, University of Leipzig, An den Tierkliniken 29, 04103 Leipzig, Germany

Corresponding author: R. von Buenau; e-mail: vbuenau{at}ardeypharm.de.

Inappropriate daily use of antimicrobial drugs for the treatment of intestinal diseases is associated with an increased risk of antibiotic resistance. Thus, the establishment of new forms of therapy is still needed. Our objective was to examine the effect of the nonpathogenic Escherichia coli strain Nissle 1917 on the prophylaxis and treatment of neonatal calf diarrhea in a hypothesis-generating study (study I) and a subsequent confirmatory clinical study (study II) under field conditions. Both trials were designed as consecutive, placebo-controlled, single-blind comparisons of 2 groups of animals. Immediately after birth, healthy calves were assigned to either the E. coli Nissle 1917 or the placebo group. The study medication was administered orally 1/d before the first feeding. The treatment was continued for the first 10 to 12 d of life. For each animal, the studies ended on d 20 to 22 of life. In both trials, the number of calves developing diarrhea was defined as the primary target criterion. A total of 335 newborn calves were included in the studies (study I: n = 172; study II: n = 163). Study I showed that the incidence of diarrhea was 65.2% under placebo and 26.5% under E. coli Nissle 1917. In study II, the corresponding figures were 63.0% under placebo and 12.2% under E. coli Nissle 1917. It can be concluded that the administration of viable E. coli bacteria, strain Nissle 1917, has a clear beneficial effect on the prophylaxis and treatment of neonatal calf diarrhea.

Key Words: Escherichia coli strain Nissle 1917 • neonatal calf diarrhea • Ponsocol




This article has been cited by other articles:


Home page
 J DAIRY SCIHome page
H. Lapierre, D. R. Ouellet, R. Berthiaume, R. Martineau, G. Holtrop, and G. E. Lobley
Distribution of 15N in Amino Acids During 15N-Leucine Infusion: Impact on the Estimation of Endogenous Flows in Dairy Cows
J Dairy Sci, July 1, 2008; 91(7): 2702 - 2714.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Dairy Science Association ®.